Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
07/2008
07/22/2008US7402558 Improved embyros implanting; prenancy
07/22/2008US7402299 Intracorporeal medicaments for photodynamic treatment of disease
07/22/2008CA2458932C Methylene-4-azasteroids
07/22/2008CA2417825C 6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
07/22/2008CA2383011C Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
07/22/2008CA2248841C Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
07/17/2008WO2008084717A1 Tricyclic compound and pharmaceutical use thereof
07/17/2008WO2007062483A8 Increasing pregnancy rates
07/17/2008US20080171853 Formed via solid-state chemistry with 4-methylbenzylhydrylamine functionalized crosslinked polystyrene resin; deblocking, deprotecting; methylation
07/17/2008US20080171700 Use Of Secretagogue For The Teatment Of Ghrelin Deficiency
07/17/2008US20080171692 Substituted amides
07/17/2008DE202007003266U1 Pharmazeutische Zusammensetzung zum Schutz vor Allergien und entzündlichen Erkrankungen Pharmaceutical composition for protection against allergies and inflammatory diseases
07/17/2008CA2674045A1 Tricyclic compound and pharmaceutical use thereof
07/16/2008EP1944301A1 Novel benzoxathiin derivative
07/16/2008EP1944298A1 Quinazoline derivative and pharmaceutical
07/16/2008EP1944290A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
07/16/2008EP1944041A1 Therapeutic agent for neurogenic pain
07/16/2008EP1944021A1 Equol level regulator
07/16/2008EP1942921A2 Combination of a dipeptidyl peptidase-4 inhibitor and an anti-hypertensive agent for the treatment of diabetes and hypertension
07/16/2008EP1506205B1 Novel azacyclic ethynyl derivatives
07/16/2008EP1446104B1 Spray drying methods
07/16/2008EP1386913B1 Pyrrole derivative
07/16/2008EP1286966B1 4-aminopiperidine derivatives and their use as medicine
07/16/2008EP1051479B1 Novel steroid-activated nuclear receptors and uses therefor
07/16/2008CN101223135A Preparation of paricalcitol and crystalline forms thereof
07/16/2008CN101219210A Agent kit containing oral insulin solid therapy
07/16/2008CN100402492C Androgen receptor suppressors in treatment of hirsutism, acne and androgenetic alopecia
07/16/2008CN100402087C Lyophilized suspended powder injection and preparation method thereof
07/16/2008CN100401912C Slowly digestable starch product
07/15/2008US7399867 1-(2-{4-[2-(4-Methanesulfonyl-phenyl)-6-methoxy-3,4-dihydro-naphthalen-1-yloxy]-phenoxy}-ethyl)-piperidine for therapy of endometriosis and/or uterine leiomyoma/leiomyomata
07/15/2008US7399829 Variants of RANKL protein
07/10/2008WO2008021422A3 Process for the preparation of indolin-2-one derivatives useful as pr modulators
07/10/2008US20080167365 Of the ACE inhibitor ramipril by mixing with the ramipril (m)ethyl ester prodrug and a pressure sensitive adhesive carrier; improved pharmacokinetics; sustained release
07/10/2008US20080167356 metabolic syndrome, diabetes, cholestatic liver disease, fibrosis; improved glucose tolerance and decreased insulin resistance; 6-[4-({[3-(2,6-dichlorophenyl)-5-(1-methylethyl)-4-isoxazolyl]methyl}oxy)phenyl]-1-naphthalenecarboxylic acid
07/10/2008US20080167283 Nandrolone 17 Beta-Carbonates
07/10/2008US20080167282 Particularly androgens, for the treatment of disorders resulting from use, especially abuse, of substances including intoxication, withdrawl, addiction, mental disorders, gambling, or recurrent criminal behavior.
07/10/2008US20080167280 Enhanced drug delivery in transdermal systems
07/10/2008US20080166768 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
07/09/2008EP1940863A2 Nitrooxy derivatives op glucocorticoids
07/09/2008EP1940837A2 Imidazopyridine compounds
07/09/2008EP1940407A2 N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamides as androgen receptor modulators
07/09/2008EP1534289B1 Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus
07/09/2008EP1523571B1 Sgk and nedd used as diagnostic and therapeutic targets
07/09/2008EP1446144B1 The use of leptin in infertility
07/09/2008EP1332133B1 Metabotropic glutamate receptor antagonists
07/09/2008CN101218245A 3-ester prodrugs of ethynylestradiol
07/09/2008CN101217964A Method for preparing and using water-based steroid pheromone compositions
07/09/2008CN101215286A Tricyclic androgen receptor modulator compounds and methods
07/09/2008CN100400042C Methods for making sustained release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
07/08/2008US7396920 Tumour suppressor and uses thereof
07/08/2008US7396859 Perturbed membrane-binding compounds
07/08/2008US7396809 Methods and reagents for treating glucose metabolic disorders
07/08/2008US7396663 Isolated polynucleotide encoding a G-protein coupled receptor
07/08/2008CA2432131C Pyrazole compounds useful as protein kinase inhibitors
07/08/2008CA2395077C Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof
07/08/2008CA2387134C Cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof
07/08/2008CA2384184C 17.beta.-acyl-17.alpha.-propynyl-11.beta.-(cyclic amino) aryl steroids and their derivatives having antagonist hormonal properties
07/03/2008WO2008079346A1 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
07/03/2008WO2008078730A1 Preparation for transnasal application
07/03/2008WO2008078725A1 Thiazepine derivative
07/03/2008WO2008077646A1 Non-steroidal progesterone receptor modulators
07/03/2008WO2008034796A3 Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors
07/03/2008WO2008033304A3 Compositions for promoting non-leaky collateral vascularization
07/03/2008WO2008027854A3 Pharmaceutical compositions comprising hgh for oral delivery
07/03/2008WO2007070355A3 Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
07/03/2008US20080161354 Stable s-nitrosothiols, method of synthesis and use
07/03/2008US20080161277 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
07/03/2008US20080161244 Analogs of gastric inhibitory polypeptide and their use for treatment of diabetes
07/03/2008US20080161240 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
07/03/2008US20080160033 Novel Screening Method
07/03/2008CA2673657A1 Use of long-acting glp-1 receptor agonists to improve insulin sensitivity and lipid profiles
07/03/2008CA2673472A1 5-cyan0-4- (pyrrolo) [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
07/02/2008EP1939203A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform
07/02/2008EP1939194A1 Bicyclic aromatic substituted pyridone derivative
07/02/2008EP1938819A2 Use of specific cyclolignans
07/02/2008EP1938818A2 Use of specific cyclolignans
07/02/2008EP1938810A1 Ameliorating agent for metabolic syndrome
07/02/2008EP1667521A4 Methods for treatment of insulin-like growth factor-1 (igf-1) deficiency
07/02/2008EP1496838A4 Substituted amides
07/02/2008EP1250148B2 Use of fsh for treating infertility
07/02/2008CN101212973A 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
07/02/2008CN101212972A 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
07/02/2008CN101212971A 4-phenyl-5-0x0-l,4,5,6,7,8-hexahydr0quin0line derivatives as medicaments for the treatment of infertility
07/02/2008CN101209075A Health care tea for female
07/02/2008CA2640046A1 2-substituted benzimidazoles as selective androgen receptor modulators (sarms)
07/01/2008US7393925 structural modification alters the biological persistence, preferably the biological half-life
07/01/2008US7393861 Derivatives of 4-aminopiperidine and their use as a medicament
07/01/2008US7393655 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder
07/01/2008US7393543 Vaginally administratable progesterone-containing tablets and method for preparing same
06/2008
06/26/2008WO2008075162A2 Selective mu opioid receptor antagonists for the treatment of female sexual dysfunction
06/26/2008WO2008075070A1 Sulfonamide derivatives for therapeutic use as fatty acid synthase inhibitors
06/26/2008WO2008074097A1 Pharmaceutical compound and composition
06/26/2008WO2008002490A3 Treatment of vasomotor symptoms with selective estrogen receptor modulators
06/26/2008US20080153899 Fatty amine drug conjugates
06/26/2008US20080153806 diagnostic test and method is provided comprising mixing blood or another biological fluid sample with a test compound and spotting the blood on filter paper for subsequent analysis of the effect of the test compound on the blood. The biological fluid can be a cerebrospinal
06/26/2008US20080153791 Administering (2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,;14bR)-10-(2-Carboxy-phenoxy)-2,4a,6a,;6b,9,9,12a-heptamethyl-13-oxo-1,2,;3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,;12a,12b,13,14b-icosahydro-picene-2-;carboxylic acid methyl ester; metabolic diseases, cancer, cell proliferation, glaucoma,
06/26/2008US20080152699 Method of treating menopausal women transdermally with testosterone
06/26/2008DE102006061913A1 New amide compounds used for treatment of gynecological diseases e.g. endometriosis, for female fertility control and female hormone replacement therapy, has general formula
06/26/2008CA2673418A1 Pharmaceutical compound and composition
06/25/2008EP1935423A2 Composition for treating and/or prophylaxis of tumors of the breast
1 ... 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 ... 290